7-117535411-G-C
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PP3PP5
The NM_000492.4(CFTR):āc.743G>Cā(p.Arg248Thr) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000547 in 1,461,702 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000492.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.743G>C | p.Arg248Thr | missense_variant, splice_region_variant | 6/27 | ENST00000003084.11 | NP_000483.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFTR | ENST00000003084.11 | c.743G>C | p.Arg248Thr | missense_variant, splice_region_variant | 6/27 | 1 | NM_000492.4 | ENSP00000003084.6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251316Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135824
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461702Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 727170
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cystic fibrosis Pathogenic:1Uncertain:1Other:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 07, 2023 | This missense change has been observed in individual(s) with azoospermia (PMID: 28801929). This sequence change replaces arginine, which is basic and polar, with threonine, which is neutral and polar, at codon 248 of the CFTR protein (p.Arg248Thr). This variant also falls at the last nucleotide of exon 6, which is part of the consensus splice site for this exon. This variant is present in population databases (rs397508792, gnomAD 0.002%). ClinVar contains an entry for this variant (Variation ID: 54053). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided, no classification provided | literature only | ClinVar Staff, National Center for Biotechnology Information (NCBI) | - | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | May 08, 2020 | CFTR c.743G>C has been previously identified in individuals with features of cystic fibrosis, but without the classic phenotype. This CFTR variant (rs397508792) is rare (<0.1%) in a large population dataset (gnomAD: 2/251316 total alleles; 0.0008%; no homozygotes). Three bioinformatic tools queried predict that this amino acid substitution would probably be damaging and the arginine residue at this position is evolutionarily conserved across most species assessed. This variant alters the last nucleotide of exon 6 (legacy exon 6a) and bioinformatic analysis predicts that this variant would affect splicing of this exon. However, this has not been confirmed experimentally to our knowledge. We consider c.743G>C to be likely pathogenic. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 13, 2024 | Variant summary: CFTR c.743G>C (p.Arg248Thr) results in a non-conservative amino acid change located in the ABC transporter type 1, transmembrane domain (IPR011527) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. Several computational tools predict a significant impact on normal splicing: Three predict the variant abolishes a 5' splicing donor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 8e-06 in 251316 control chromosomes (gnomAD). c.743G>C has been reported in the literature in individuals affected with CFTR-Related Diseases, including an adult man diagnosed with azoospermia/male infertility (e.g. Oud_2017) and one young man diagnosed with CFTR-RD hepatopathy with elevated sweat chloride concentrations (e.g. Polizzi_2011). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 21931512, 28801929). ClinVar contains an entry for this variant (Variation ID: 54053). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at